title: Photodynamic therapy for iatrogenic CNV due to laser photocoagulation in central serous chorioretinopathy.
abstract: The authors report the result of photodynamic therapy for iatrogenic choroidal neovascularization from focal argon laser photocoagulation in a case with central serous chorioretinopathy. A 45-year-old woman who developed choroidal neovascularization after focal argon laser photocoagulation for chronic central serous chorioretinopathy was treated with ocular photodynamic therapy with verteporfin. Choroidal neovascularization became inactive clinically a month after photodynamic therapy. Fluorescein angiography and optical coherence tomography demonstrated the resolved choroidal neovascularization. Baseline visual acuity improved from 20/40 to 20/20 after photodynamic therapy. The patient's condition remained stable 2 years postoperatively. Photodynamic therapy was beneficial for the outcome of iatrogenic choroidal neovascularization that developed after laser treatment for longstanding central serous chorioretinopathy.
authors.affiliation: Beyoglu Eye Training and Research Hospital, Istanbul, Turkey.
authors.forename: Mehmet
authors.initials: M
authors.lastname: Cakir
authors.forename: Osman
authors.initials: O
authors.lastname: Cekiç
authors.forename: Omer F
authors.initials: OF
authors.lastname: Yilmaz
mesh_terms: D015862:Choroid Diseases / Q000601:surgery*; D020256:Choroidal Neovascularization / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D005260:Female; D005451:Fluorescein Angiography; D006801:Humans; D007049:Iatrogenic Disease; D017075:Laser Coagulation / Q000009:adverse effects*; D054020:Lasers, Gas / Q000627:therapeutic use; D008875:Middle Aged; D010778:Photochemotherapy; D017319:Photosensitizing Agents / Q000627:therapeutic use; D011166:Porphyrins / Q000627:therapeutic use; D012164:Retinal Diseases / Q000601:surgery*; D044967:Serum; D041623:Tomography, Optical Coherence; D016896:Treatment Outcome; D000077362:Verteporfin; D014792:Visual Acuity
chemical_list: D017319:Photosensitizing Agents; D011166:Porphyrins; D000077362:Verteporfin